Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€12.20

€12.20

2.520%
0.3
2.520%
€17.17

€17.17

 
18.12.25 / Frankfurt WKN: A1T7BJ / Symbol: ENTA / Name: Enanta / Stock / Biotechnology & Medical Research / Small Cap /
Latest predictions
€14.61
14.11.25
16.98%
buy
€17.04
01.10.25
37.02%
buy
€17.04
01.10.25
37.02%
buy
€23.89
30.09.25
16.98%
buy
€10.23
15.09.25
85.07%
buy
€20.51
02.09.25
60.53%
buy
Best running prediction
€17.43
11.02.25
130.19%
buy
Your prediction

Enanta Pharmaceuticals Inc. Stock

Enanta Pharmaceuticals Inc. gained 2.520% today.
Enanta Pharmaceuticals Inc. is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
With a target price of 17 € there is a positive potential of 39.34% for Enanta Pharmaceuticals Inc. compared to the current price of 12.2 €.
So far the community has only identified positive things for Enanta Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Enanta Pharmaceuticals Inc. in the next few years

Pros
?
C******** o* t** e**********
?
B****
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Enanta Pharmaceuticals Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Enanta Pharmaceuticals Inc. 2.520% 0.847% 13.333% 116.364% 112.500% -72.326% -66.384%
Ardelyx Inc. -1.380% -3.738% -3.237% 8.980% -2.477% 162.325% -16.141%
Krystal Biotech -1.540% -5.188% 12.733% 31.921% 30.880% 163.841% -
Evolus Inc -1.680% -1.681% 1.739% -45.833% -44.286% -10.000% 63.728%

Comments

Prediction Buy
Perf. (%) 16.98%
Target price 14.612
Change
Ends at 14.11.26

Enanta Pharmaceuticals (NASDAQ:ENTA) is now covered by analysts at JPMorgan Chase & Co.. They set an "overweight" rating and a $17.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 37.02%
Target price 17.036
Change
Ends at 01.10.26

Enanta Pharmaceuticals (NASDAQ:ENTA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 37.02%
Target price 17.036
Change
Ends at 01.10.26

Enanta Pharmaceuticals (NASDAQ:ENTA) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.
Ratings data for ENTA provided by MarketBeat
Show more